PTK2 and pulmonary fibrosis: In chronic fibrotic disorders, FAK activity is elevated in intralesional skin fibroblasts from patients with systemic sclerosis (28) and in lung myofibroblasts from patients with idiopathic pulmonary fibrosis (29).